Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-24-000486

Chief Operating Officer gave up 3,098 shares (to pay taxes)

  • Chief Operating Officer acquired 8,952 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cittadine Andrew Chief Operating Officer 2023-12-31 Option exercise +8,952 54,868 D: show line 1 in the form
Cittadine Andrew Chief Operating Officer 2023-12-31 Shares withheld for taxes −3,098 $0.34 $1,054 51,770 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cittadine Andrew Chief Operating Officer 2023-12-31 Option exercise · Restricted Stock Units −8,952 91,175 D: show line 3 in the form
Loading xslF345X05/rdgdoc.xml…